Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 120Carcinoma, Hepatocellular 67Ovarian Neoplasms 63Neoplasms 36Carcinoma, Non-Small-Cell Lung 35Fallopian Tube Neoplasms 29Glioblastoma 23Brain Neoplasms 23Colonic Neoplasms 21Breast Neoplasms 19Neoplasm Metastasis 17Endometrial Neoplasms 17Uterine Cervical Neoplasms 15Stomach Neoplasms 15Rectal Neoplasms 15Lung Neoplasms 14Liver Neoplasms 11Triple Negative Breast Neoplasms 10Melanoma 8Glioma 8Carcinoma, Renal Cell 8Carcinoma, Ovarian Epithelial 8Biliary Tract Neoplasms 8Recurrence 7Colorectal Cancer Metastatic 7Squamous Cell Carcinoma of Head and Neck 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Advanced Solid Tumors 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5

Interventions

pembrolizumab 4Proton Therapy 3toripalimab 1spartalizumab 1patritumab deruxtecan 1osimertinib 1mirdametinib 1leronlimab 1amivantamab 1Valganciclovir 1Radiotherapy 1Paclitaxel 1Lacteol 1Interleukin-2 1Docetaxel 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1BGB-283 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × Bevacizumab × 1 year × Clear all
NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
160 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡